35 articles - From Friday Sep 05 2025 to Friday Sep 12 2025
Guidelines and related publications, position statements, white papers, technical reviews, consensus statements, etc…
| J Crohns Colitis |
|---|
meta-analyses and systematic reviews
| Am J Clin Nutr |
|---|
Effects of carbohydrate-restricted diets and macronutrient replacements on cardiovascular health and body composition in adults: A meta-analysis of randomized trials. CRDs improved cardiovascular health and body composition, especially in diets with combined macronutrient replacement. Potential adverse effects, including LDL elevation and lean mass loss, warrant clinical monitoring. Registration number For body composition PROSPERO CRD420251043066 ( for cardiovascular health CRD420251011748 ( |
RCT, clinical trials, retrospective studies, etc…
| Am J Clin Nutr |
|---|
Associations of body mass index, waist circumference, and weight-adjusted waist index with body composition and biomarkers: A multinational pooled analysis. Our data suggest that WWI is associated with unhealthy body composition (high fat, low fat-free mass) in populations of diverse age, sex, and race/ethnicities and may serve as an alternative index to BMI and WC. |
Can correction of low vitamin D status in infancy program for a leaner body composition?: a post-trial follow-up study of whole body lean mass in early childhood. The greater whole body lean mass observed in infants in our published trial of 1000 IU/d of vitamin D supplementation compared to 400 IU/d was maintained post-trial at 24 months in accordance with greater length. Confirmation of these observations, and whether these extend into later childhood, requires new trials. |
Impact of sustainable diets on micronutrient intakes and status: outcomes of the MyPlanetDiet randomized controlled trial. A diet based on sustainable dietary principles lowered dietary GHGE and several MNs, despite provision of daily servings of dairy, three weekly servings of animal protein and two servings of fish. These findings show that MNs should be considered in developing environmentally protective diets. Clinical trial registry (NCT05253547). |
Interaction between dietary cholesterol intake and genetic variants for cholesterol absorption in relation to coronary artery disease mortality: a prospective analysis in the Singapore Chinese Health Study. DC intake was more strongly associated with CAD mortality in Singapore Chinese with greater genetic susceptibility to cholesterol absorption. |
Predicting total body water in infants aged 0.5-24 months and the implications for measuring breast milk intake: a secondary analysis of isotope dilution data. The equation used in DTM calculations provides biased TBW estimates. This has implications for measuring breast milk intake and nonmilk water intake and our understanding of nutritional needs during the first 2 y of life. |
| Inflamm Bowel Dis |
Branched-Chain Amino Acids Exacerbate Colitis Progression by Lowering Colonic Fumarate Levels. BCAA supplementation exacerbates DSS-induced colitis in mice. This effect is mediated by detrimental changes in gut microbiota composition and metabolome. DMF treatment shows promise to mitigate these adverse effects, suggesting potential therapeutic avenues to manage BCAA-induced colitis exacerbation and reinforcing the role of microbiome in UC. These findings underscore the caution needed with the use of BCAAs during inflammatory conditions. |
Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City. Our study is the first to identify significant differences in patient demographics, disease phenotype, treatments and clinical outcomes between patients treated for IBD at a private nonprofit vs public hospital. Our data suggest that social determinants of health drive disparities in the utilization of healthcare facilities. |
Patient-Specific Regulatory Network Rewiring in Inflammatory Bowel Disease: How Genetic Polymorphisms Divert Incoming Signals and Contribute to Disease Pathogenesis. In summary, this work highlights the importance of personalized investigation of signaling processes upstream of genetic polymorphisms to gain a more comprehensive understanding of IBD pathogenesis. |
The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn's Disease. The presence of sarcopenia at the diagnosis increases the risk of clinical relapses in the first year of diagnosis. Magnetic resonance evaluation of the tPMA could therefore help identify children at higher risk of worse outcomes. |
| J Crohns Colitis |
Blood proteomic signatures associated with disease activity in Inflammatory Bowel Diseases. Our findings reveal inflammatory blood proteomic signatures associated with post-operative recurrence and biologic treatment failure in IBD. Several key biomarkers were identified. These results support the rationale for personalized approaches, including combination therapies targeting multiple pathways.ClincialTrials.gov number, NCT02693340 and NCT02693340. |
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID. In this real-world study evaluating SC VDZ intensification, a SFCr was observed in at least one third of IBD patients at 3 months, suggesting the benefit of this strategy in clinical practice. |
Unravelling the genetic architecture of inflammatory bowel disease multiplex families with rare and common variant polygenic risk scores. Multiplex IBD families show diverse genetic architecture, with almost half showing a high burden of common and/or rare risk variants. While genetic predispositions to smoking influences IBD risk in sporadic cases, it provides limited insights into familial IBD. These findings highlight the genetic complexity within multiplex families and the need for tailored research approaches such as risk stratification and genetic screening strategies. |
| Pancreatology |
Outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1 treatment: A propensity score-matched analysis. GnP was associated with improved OS compared to FOLFIRINOX for patients with early recurrence after adjuvant S-1. |
Plenty of the editorials are available as full text through the publisher website using the provided link
| Am J Clin Nutr |
|---|
A scoping review on the possible immunometabolic properties of the furan fatty acid metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid. Epidemiological evidence further supports that elevated CMPF levels are associated with reduced susceptibility to infections. Collectively, there is compelling evidence supporting the hypothesis that CMPF is a bioactive metabolite with systemic metabolic and immunomodulatory effects, warranting further in-depth investigation. |
| Pancreatology |
misc publications eg case reports, tools of the trade, images of the month, etc…
| Am J Clin Nutr |
|---|
| Liver Transpl |
| Pancreas |
Letters to the editors and authors’ replies
| Am J Clin Nutr |
|---|
| Pancreatology |